And Phase 2:


Bio-chip implant arrives
for cashless transactions
Announcement at global security confab unveils syringe-injectable ID microchip


At a global security conference held today in Paris, an American company announced a new syringe-injectable microchip implant for humans, designed to be used as a fraud-proof payment method for cash and credit-card transactions.

The chip implant is being presented as an advance over credit cards and smart cards, which, absent biometrics and appropriate safeguard technologies, are subject to theft, resulting in identity fraud.

Identity fraud costs the banking and financial industry some $48 billion a year, and consumers $5 billion, according to 2002 Federal Trade Commission estimates.
http://www.worldnetdaily.com/news/ar...TICLE_ID=35766